Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Nov-2009
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 5 of 5)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: TRANSCEPT PHARMA -- TSPT 1 $4 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: ANX , MIPI , STEM , TSPT -- DRUGS 3 $4 View Abstract
13-Nov-09 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of TRANSCEPT PHARMACEUTICALS including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 3 $20 View Abstract
3-Nov-09 EconomicInvestor N/A "The Economy Matters" Report for TSPT: the economy's impact on TSPT's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
28-Oct-09 Global Markets Direct Global Markets Direct Transcept Pharmaceuticals, Inc. Financial Analysis Review 12 $300 View Abstract

Independent Reports (Showing 1 to 5 of 5)

Release
Date Contributor Author Title Pages Price More Info
20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: TRANSCEPT PHARMA -- TSPT 1 $4 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: ANX , MIPI , STEM , TSPT -- DRUGS 3 $4 View Abstract
13-Nov-09 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of TRANSCEPT PHARMACEUTICALS including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 3 $20 View Abstract
3-Nov-09 EconomicInvestor N/A "The Economy Matters" Report for TSPT: the economy's impact on TSPT's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
28-Oct-09 Global Markets Direct Global Markets Direct Transcept Pharmaceuticals, Inc. Financial Analysis Review 12 $300 View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.